Dong-A Socio Holdings completes merger of wholly owned unit Dong-A Pharmaceutics
Bitget2026/10/02 06:22- Dong-A Socio Holdings completed a merger of its wholly owned unit Dong-A Pharmaceutical into the surviving company, also renamed Dong-A Pharmaceutical.
- The deal used a 1:0 merger ratio with no new shares issued and no cash consideration paid.
- Merger effective date was Oct. 1, 2026; registration was scheduled for Oct. 2, 2026.
- Objection notices were filed by 103 shareholders covering 6,166 shares, equal to 0.09% of shares outstanding.
- Combined pro forma totals as of June 30, 2026: assets 1,411,503 million won; liabilities 463,517 million won; equity 947,986 million won.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Besent “Extinguishes Fire”: Rising US Treasury yields are a global phenomenon, dismisses concerns over AI bubble
U.S. Treasury Secretary Janet Yellen defended the rise in U.S. Treasury yields, stating that this increase is a global phenomenon rather than unique to the United States, and does not warrant excessive concern. She partially attributed inflationary pressures to higher oil prices caused by the Iran conflict, and expects the energy shock to subside as hostilities ease. Yellen refuted the notion of an AI bubble, arguing that investments by major tech companies are grounded in solid business logic.